Skip to main content
SpringerLink
Log in

Survival benefit with alternating chemotherapy for lung cancer does not appear to be associated with large additional costs

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Survival benefit with alternating chemotherapy for lung cancer does not appear to be associated with large additional costs. Inpharma Wkly. 675, 6 (1989). https://doi.org/10.1007/BF03296379

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03296379

Keywords

Search

Navigation